🟢 Context Therapeutics is trading 8% up in pre-market with no confirmed catalyst

Context Therapeutics is trading at $0.54, up 7.98%, after no confirmed company-specific catalyst was identified for August 24, 2026.

• The latest investor-relations release was dated August 5, 2026, with no August 24 announcement listed.
• Broader markets are mixed to modestly lower and do not clearly explain the move.
• The gain appears to reflect low-volume or speculative activity rather than a verified fundamental catalyst.